BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12526179)

  • 21. Lentiviral vectors that carry anti-HIV shRNAs: problems and solutions.
    ter Brake O; Berkhout B
    J Gene Med; 2007 Sep; 9(9):743-50. PubMed ID: 17628029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Poxviral/retroviral chimeric vectors allow cytoplasmic production of transducing defective retroviral particles.
    Holzer GW; Falkner FG
    Methods Mol Med; 2003; 76():565-78. PubMed ID: 12526185
    [No Abstract]   [Full Text] [Related]  

  • 23. Non-HIV lentiviral vectors: interview with Alan Kingsman.
    Kingsman A
    J Gene Med; 1999; 1(6):441-3. PubMed ID: 10753070
    [No Abstract]   [Full Text] [Related]  

  • 24. Safe two-plasmid production for the first clinical lentivirus vector that achieves >99% transduction in primary cells using a one-step protocol.
    Lu X; Humeau L; Slepushkin V; Binder G; Yu Q; Slepushkina T; Chen Z; Merling R; Davis B; Chang YN; Dropulic B
    J Gene Med; 2004 Sep; 6(9):963-73. PubMed ID: 15352069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Helper plasmids for production of HIV-1-derived vectors.
    Fuller M; Anson DS
    Hum Gene Ther; 2001 Nov; 12(17):2081-93. PubMed ID: 11747598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A synthetic Rev-independent bovine immunodeficiency virus-based packaging construct.
    Molina RP; Ye HQ; Brady J; Zhang J; Zimmerman H; Kaleko M; Luo T
    Hum Gene Ther; 2004 Sep; 15(9):865-77. PubMed ID: 15353041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors influencing the titer and infectivity of lentiviral vectors.
    Logan AC; Nightingale SJ; Haas DL; Cho GJ; Pepper KA; Kohn DB
    Hum Gene Ther; 2004 Oct; 15(10):976-88. PubMed ID: 15585113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Self-inactivating lentiviral vectors and a sensitive Cre-loxP reporter system.
    Chang LJ; Zaiss AK
    Methods Mol Med; 2003; 76():367-82. PubMed ID: 12526175
    [No Abstract]   [Full Text] [Related]  

  • 29. Novel bovine lentiviral vectors based on Jembrana disease virus.
    Metharom P; Takyar S; Xia HH; Ellem KA; Macmillan J; Shepherd RW; Wilcox GE; Wei MQ
    J Gene Med; 2000; 2(3):176-85. PubMed ID: 10894263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Replicative fidelity of lentiviral vectors produced by transient transfection.
    Laakso MM; Sutton RE
    Virology; 2006 May; 348(2):406-17. PubMed ID: 16469344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation of a flexible cell line with regulatable, high-level expression of HIV Gag/Pol particles capable of packaging HIV-derived vectors.
    Sparacio S; Pfeiffer T; Schaal H; Bosch V
    Mol Ther; 2001 Apr; 3(4):602-12. PubMed ID: 11319923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-Titer Production of HIV-Based Lentiviral Vectors in Roller Bottles for Gene and Cell Therapy.
    Olgun HB; Tasyurek HM; Sanlioglu AD; Sanlioglu S
    Methods Mol Biol; 2019; 1879():323-345. PubMed ID: 29797007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant modified vaccinia virus ankara expressing the surface gp120 of simian immunodeficiency virus (SIV) primes for a rapid neutralizing antibody response to SIV infection in macaques.
    Ourmanov I; Bilska M; Hirsch VM; Montefiori DC
    J Virol; 2000 Mar; 74(6):2960-5. PubMed ID: 10684319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasmovirus: replication cycle of a novel nonviral/viral vector for gene transfer.
    Morozov VA; Noguiez-Hellin P; Laune S; Tamboise E; Salzmann JL; Klatzmann D
    Cancer Gene Ther; 1997; 4(5):286-93. PubMed ID: 9345600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disclosing the Parameters Leading to High Productivity of Retroviral Producer Cells Lines: Evaluating Random Versus Targeted Integration.
    Bandeira VS; Tomás HA; Alici E; Carrondo MJ; Coroadinha AS
    Hum Gene Ther Methods; 2017 Apr; 28(2):78-90. PubMed ID: 28301970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genomic integration occurs in the packaging cell via unexported lentiviral precursors.
    Mosabbir AA; Truong K
    Biotechnol Lett; 2016 Oct; 38(10):1715-21. PubMed ID: 27341835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chimeric HIV-1 and HIV-2 lentiviral vectors with added safety insurance.
    Sachdeva G; D'Costa J; Cho JE; Kachapati K; Choudhry V; Arya SK
    J Med Virol; 2007 Feb; 79(2):118-26. PubMed ID: 17177309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of High-Titer Pseudotyped Lentiviral Vectors.
    Hu S; Li M; Akkina R
    Methods Mol Biol; 2019; 1937():125-134. PubMed ID: 30706393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lentiviral vectors.
    Loewen N; Poeschla EM
    Adv Biochem Eng Biotechnol; 2005; 99():169-91. PubMed ID: 16568892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absence of Replication-Competent Lentivirus in the Clinic: Analysis of Infused T Cell Products.
    Cornetta K; Duffy L; Turtle CJ; Jensen M; Forman S; Binder-Scholl G; Fry T; Chew A; Maloney DG; June CH
    Mol Ther; 2018 Jan; 26(1):280-288. PubMed ID: 28970045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.